Pancreatic Cancer Research

ResearcherNebraska Medical CenterActive in the last 2 years

Sugandha Saxena

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4226-9318; OpenAlex author ID A5068502433. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.1096/fba.2025-00265↗
  2. Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216185↗
  3. Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma. Co-author PMID 35141005↗
  4. Host Cxcr2-Dependent Regulation of Pancreatic Cancer Growth, Angiogenesis, and Metastasis. First author DOI 10.1016/j.ajpath.2021.01.002↗
  5. Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer. Co-author DOI 10.3390/cancers13040818↗
  6. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. First author DOI 10.1096/fj.201902990r↗
  7. Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells. Co-author DOI 10.1186/s12885-018-5204-x↗
  8. Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Co-author DOI 10.18632/oncotarget.23644↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rakesh K. Singh · 7 shared papers, 2018–2026 · strength 1.04
  2. Surinder K. Batra · 6 shared papers, 2018–2026 · strength 0.93
  3. Abhilasha Purohit · 6 shared papers, 2018–2023 · strength 0.76
  4. Dipakkumar R. Prajapati · 5 shared papers, 2020–2023 · strength 0.70
  5. Caitlin Molczyk · 3 shared papers, 2022–2026 · strength 0.63
  6. Reegan Sturgeon · 2 shared papers, 2023–2026 · strength 0.49
  7. Pranita Atri · 3 shared papers, 2018–2022 · strength 0.34
  8. Satyanarayana Rachagani · 3 shared papers, 2018–2021 · strength 0.30
  9. Namita Bhyravbhatla · 1 shared paper, 2026 · strength 0.30
  10. Rick Bhatia · 1 shared paper, 2026 · strength 0.30
  11. Sushil Kumar · 1 shared paper, 2026 · strength 0.30
  12. Sushil Kumar K · 2 shared papers, 2020–2023 · strength 0.29
  13. Michael Anthony Hollingsworth · 2 shared papers, 2021–2022 · strength 0.26
  14. Paul M. Grandgenett · 2 shared papers, 2021–2022 · strength 0.26
  15. Mohammad I. Awaji · 2 shared papers, 2018–2020 · strength 0.18
  16. Rakesh K. Singh · 1 shared paper, 2022 · strength 0.14
  17. Sukhwinder Kaur · 1 shared paper, 2022 · strength 0.14
  18. Maneesh Jain · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.